Investor Stock List
Ranked #6,115 of 8,699 institutional investors

Diadema Partners LP

Morristown, NJ

$204M
US stock portfolio at live prices · today −$3.4M (−1.62%)
Live prices, last trade 10:49 AM ET
Value at quarter end (Q3 2026)
$219M
Change from Q2 2026
−$45.2M (−17.10%)
Positions
71 · 30 new, 27 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $324M of stock, put options on $188M, $49.0M of convertible notes and other principal-amount securities. $7.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
UTHR 12.6%COGT 8.56%BMRN 7.64%ABVX 5.98%RVMD 5.64%
StockSharesValue, live% of portfoliovs Q2 2026
UTHR United Therapeutics Corporation46,222$25.7M12.6%Reduced −13%
COGT Cogent Biosciences, Inc.641,947$17.5M8.56%Added +30%
BMRN BioMarin Pharmaceutical Inc.255,383$15.6M7.64%Reduced −18%
ABVX ABIVAX Société Anonyme178,444$12.2M5.98%Added +9%
RVMD Revolution Medicines, Inc.70,004$11.5M5.64%Reduced −50%
VKTX Viking Therapeutics, Inc.433,166$11.1M5.43%Reduced −2%
BBIO BridgeBio Pharma, Inc.103,960$8.0M3.93%New
VRDN Viridian Therapeutics, Inc.257,076$7.9M3.89%Added +157%
LQDA Liquidia Corporation120,000$6.7M3.26%New
IMCR Immunocore Holdings plc221,764$5.9M2.88%Reduced −13%
REPL Replimune Group, Inc.305,000$5.8M2.82%New
JNJ Johnson & Johnson17,000$4.6M2.27%Reduced −23%
FDMT 4D Molecular Therapeutics, Inc.421,107$4.5M2.20%Reduced −26%
PCVX Vaxcyte, Inc.72,850$4.2M2.06%Added +62%
KOD Kodiak Sciences Inc.38,991$3.9M1.89%Reduced −82%
SUPN Supernus, Inc.117,512$3.4M1.68%Added +74%
RYTM Rhythm Pharmaceuticals, Inc.30,000$3.4M1.67%New
MBX MBX Biosciences, Inc.60,000$3.1M1.53%New
INSM Insmed Incorporated18,497$2.7M1.32%New
SLN Silence Therapeutics plc135,000$2.7M1.31%New
RCUS Arcus Biosciences, Inc.153,810$2.5M1.21%Reduced −31%
MNKD MannKind Corporation604,025$2.4M1.18%Added +3,674%
CRVS Corvus Pharmaceuticals, Inc.204,811$2.0M0.97%Reduced −31%
IVA Inventiva S.A.553,126$1.8M0.90%Reduced −25%
BCRX BioCryst Pharmaceuticals, Inc.250,000$1.8M0.89%New
EWTX Edgewise Therapeutics, Inc.44,346$1.8M0.88%Reduced −84%
SPRB Spruce Biosciences, Inc.40,435$1.6M0.79%Added +35%
TSHA Taysha Gene Therapies, Inc.422,619$1.6M0.77%Reduced −19%
JBIO Jade Biosciences, Inc.91,259$1.4M0.69%New
AMLX Amylyx Pharmaceuticals, Inc.53,152$1.4M0.68%New
ORKA Oruka Therapeutics, Inc.13,169$1.3M0.61%Reduced −53%
AVTX Avalo Therapeutics, Inc.181,947$1.2M0.61%New
BCYC Bicycle Therapeutics plc398,869$1.2M0.58%Reduced −14%
MLTX MoonLake Immunotherapeutics100,000$1.1M0.54%New
RLMD Relmada Therapeutics, Inc.361,367$1.0M0.51%Unchanged
VERA Vera Therapeutics, Inc.38,008$994K0.49%Reduced −34%
PHAT Phathom Pharmaceuticals, Inc.179,950$880K0.43%Added +38%
MLYS Mineralys Therapeutics, Inc.50,000$698K0.34%Reduced −11%
SLS SELLAS Life Sciences Group, Inc.50,000$697K0.34%New
LRMR Larimar Therapeutics, Inc.185,705$578K0.28%Added +27%
CTNM Contineum Therapeutics, Inc.64,549$568K0.28%Reduced −46%
TNGX Tango Therapeutics, Inc.25,000$560K0.27%New
PTHS Pelthos Therapeutics Inc.80,760$549K0.27%Added +226%
KARD Kardigan, Inc.43,972$537K0.26%New
MGNX MacroGenics, Inc.262,059$535K0.26%Reduced −30%
FULC Fulcrum Therapeutics, Inc.133,385$495K0.24%New
QNRX Quoin Pharmaceuticals, Ltd.146,446$489K0.24%New
NBP NovaBridge Biosciences500,000$484K0.24%New
ELVN Enliven Therapeutics, Inc.10,000$468K0.23%Unchanged
TRDA Entrada Therapeutics, Inc.100,000$447K0.22%New
SMMT Summit Therapeutics Inc.41,887$429K0.21%Reduced −30%
XENE Xenon Pharmaceuticals Inc.10,000$376K0.18%New
NRIX Nurix Therapeutics, Inc.21,539$285K0.14%Reduced −82%
TLPH Talphera, Inc.378,037$276K0.14%Added +146%
AEMD Aethlon Medical, Inc.50,000$246K0.12%New
ARDX Ardelyx, Inc.77,133$228K0.11%Reduced −75%
AYTU Aytu BioPharma, Inc.67,186$178K<0.1%Reduced −55%
OCGN Ocugen, Inc.200,000$159K<0.1%Unchanged
ATTO Attovia Therapeutics, Inc.9,700$146K<0.1%New
ABEO Abeona Therapeutics Inc.51,117$125K<0.1%New
HRTX Heron Therapeutics, Inc.458,723$122K<0.1%Unchanged
LLY Eli Lilly and Company60$82K<0.1%New
PALI Palisade Bio, Inc.69,533$66K<0.1%New
CLRB Cellectar Biosciences, Inc.71,382$61K<0.1%Reduced −48%
TVRD Tvardi Therapeutics, Inc.48,491$45K<0.1%Added +192%
ENTA Enanta Pharmaceuticals, Inc.5,503$42K<0.1%New
ELTX Elicio Therapeutics, Inc.9,440$14K<0.1%New
OTLK Outlook Therapeutics, Inc.35,000$13K<0.1%New
MXCT MaxCyte, Inc.8,190$11K<0.1%New
APRE Aprea Therapeutics, Inc.28,872$9K<0.1%Reduced −36%
NTLA Intellia Therapeutics, Inc.124$1K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
NVO Novo Nordisk A/S100,000$3.9M
ZYME Zymeworks Inc.142,132$3.9M
RLAY Relay Therapeutics, Inc.230,677$3.7M
XERS Xeris Biopharma Holdings, Inc.132,746$2.2M
SYRE Spyre Therapeutics, Inc.15,000$1.4M
PEPG PepGen Inc.373,284$1.4M
UNCY Unicycive Therapeutics, Inc.303,676$1.1M
RIGL Rigel Pharmaceuticals, Inc.22,816$929K
HRMY Harmony Biosciences Holdings, Inc.26,864$893K
GLUE Monte Rosa Therapeutics, Inc.78,391$678K
CRBP Corbus Pharmaceuticals Holdings, Inc.301,264$667K
BIOA BioAge Labs, Inc.146,334$659K
VYGR Voyager Therapeutics, Inc.413,642$655K
PGEN Precigen, Inc.135,293$581K
RNAC Cartesian Therapeutics, Inc.87,057$538K
EQ Equillium, Inc.400,282$460K
DFTX Definium Therapeutics, Inc.15,451$449K
AMGN Amgen Inc.593$262K
CUE Cue Biopharma, Inc.48,369$209K
FHTX Foghorn Therapeutics Inc.66,908$117K
LAKE Lakeland Industries, Inc.14,108$114K
MNPR Monopar Therapeutics Inc.1,630$111K
ANNX Annexon, Inc.27,516$90K
NXTC NextCure, Inc.7,742$51K
KLRA Kailera Therapeutics, Inc.3,621$41K
UPB Upstream Bio, Inc.19,093$36K
SPRY ARS Pharmaceuticals, Inc.4,860$16K